Search

13 results for “type 2 diabetes mellitus”

• Research ArticleOpen Access

  Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients with Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic

  Nor Humaira Mohd Tajudin, Mathumalar Loganathan Fahrni, Rohana Abdul Ghani, Mohd Hazriq Awang, Hitesh Chopra, Ali Saleh Alkhoshaiban

  Vol. 15 · Issue 4 · pp. 389–399

  https://doi.org/10.1177/0976500X241268964
  Full text ↗PDF

• Research ArticleOpen Access

  Use of Fixed-dose Combination Therapy with Remogliflozin and Vildagliptin as an Add-on Drug in Improving the Glycemic Control of Type 2 Diabetes Mellitus: An Observational Study

  Velammal Petchiappan, Elsa Mathew, Josna Jose, Mohamed Fardan, Yoganathan Chidambaram, Saravanan Thangavelu

  Vol. 14 · Issue 1 · pp. 72–78

  https://doi.org/10.1177/0976500X231175219
  Full text ↗PDF

• Research PaperOpen Access

  Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?

  Jayesh Dalpatbhai Solanki, Amit H. Makwana, Hemant B. Mehta, Pradnya A. Gokhale, Chinmay J. Shah

  Vol. 7 · Issue 2 · pp. 87–92

  https://doi.org/10.4103/0976-500X.184772
  Full text ↗PDF

• Research LetterOpen Access

  Prescribing pattern of drugs for cardiovascular co-morbidities in type 2 diabetes mellitus in a tertiary care Indian hospital

  Dakshinamurthy Nishanthini, Balan Aravinda Kumar, Chandrashekaran Girish, Sadasivam Balakrishnan

  Vol. 5 · Issue 1 · pp. 54–55

  https://doi.org/10.4103/0976-500X.124424
  Full text ↗PDF

• Research PaperOpen Access

  Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients

  Suyog Sindhu, Hemant Kumar Singh, Mohammad Tariq Salman, Jalees Fatima, Vinod Kumar Verma

  Vol. 2 · Issue 4 · pp. 261–265

  https://doi.org/10.4103/0976-500X.85954
  Full text ↗PDF

• Educational ForumOpen Access

  Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

  Darshan J. Dave

  Vol. 2 · Issue 4 · pp. 230–235

  https://doi.org/10.4103/0976-500X.85934
  Full text ↗PDF

• Research PaperOpen Access

  Comparison of McAuley/fasting insulin indices with ATP III clinical criteria for the diagnosis of insulin resistance in type 2 diabetes mellitus

  L. M. M., T. P. P.

  Vol. 2 · Issue 3 · pp. 165–166

  https://doi.org/10.4103/0976-500X.83280
  Full text ↗PDF

• Research LettersOpen Access

  Effect of silymarin in diabetes mellitus patients with liver diseases

  Manonmani Alvin Jose, Anjana Abraham, M. P. Narmadha

  Vol. 2 · Issue 4 · pp. 287–289

  https://doi.org/10.4103/0976-500X.85950
  Full text ↗PDF

• Case ReportOpen Access

  Insulin glargine overdose

  Fatma Sarı Doğan, Özge Ecmel Onur, Arzu Denizbaşı Altınok, Özlem Güneysel

  Vol. 3 · Issue 4 · pp. 333–335

  https://doi.org/10.4103/0976-500X.103694
  Full text ↗PDF

• Review ArticleOpen Access

  Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon

  Vishal Sehgal, Sukhminder Jit Singh Bajwa, Rinku Sehgal, John A Consalvo

  Vol. 5 · Issue 4 · pp. 227–231

  https://doi.org/10.4103/0976-500X.142428
  Full text ↗PDF

• Review ArticleOpen Access

  Adipocytokines: The pied pipers

  Hardik Gandhi, Aman Upaganlawar, Balaraman R

  Vol. 1 · Issue 1 · pp. 9–10

  https://doi.org/10.4103/0976-500X.64530
  Full text ↗PDF

• Case ReportOpen Access

  Bullous Drug Reaction with Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

  K. Geetha, Puja Puja

  Vol. 13 · Issue 1 · pp. 99–101

  https://doi.org/10.1177/0976500X221080309
  Full text ↗PDF

• CommentaryOpen Access

  The metabolic syndrome and schizophrenia: A comorbidity or an association?

  Vol. 4 · Issue 3 · pp. 174–175

  Full text ↗PDF